Literature DB >> 4959953

Cyclophosphamide. Evaluation in recurrent and progressive ovarian cancer.

D G Decker, G D Malkasian, E Mussey, C E Johnson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 4959953

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


× No keyword cloud information.
  2 in total

Review 1.  Comparative activity of ifosfamide and cyclophosphamide.

Authors:  W Brade; S Seeber; K Herdrich
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

2.  GluN2A-selective positive allosteric modulator-nalmefene-flumazenil reverses ketamine-fentanyl-dexmedetomidine-induced anesthesia and analgesia in rats.

Authors:  Chunzhu Li; Jia Yan; Dewei Tang; Jidong Zhu; Chen Huang; Yu Sun; Rong Hu; Hao Wang; Chaoying Fu; Yelin Chen; Hong Jiang
Journal:  Sci Rep       Date:  2020-03-24       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.